NR1H3 and metabolic dysfunction-associated steatotic liver disease: In an interesting in vivo study on non-alcoholic fatty liver disease (NAFLD), it is observed that upregulation of miR-155 reduces hepatic lipid accumulation by suppressing the liver X receptor alpha (LXRα)-dependent lipogenic signaling pathway.